Pressure delivery of AS-ICAM-1 ODN with LFA-1 mAb reduces reperfusion injury in cardiac allografts

Annals of Thoracic Surgery

Volumn 68, Issue 1, 1999, Pages 119-124

  Feeley, Brian T ^a   Park, Aric K ^a   Alexopoulos, Sophoclis ^a   Hoyt, E Grant ^a   Ennen, Michael P ^a   Poston Jr , Robert S ^a   Robbins, Robert C ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE; INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY; MYELOPEROXIDASE;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE THERAPY; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

ANIMALS; ANTIBODIES, MONOCLONAL; ATMOSPHERIC PRESSURE; HEART TRANSPLANTATION; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NECROSIS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PEROXIDASE; RATS; RATS, INBRED ACI; RATS, INBRED STRAINS; TRANSPLANTATION, HETEROTOPIC;

EID: 0032806945     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00503-2     Document Type: Article

References (23)

1. Milligan C.F., Matteucci M.D., Martin J.C. Current concepts in antisense drug design. J Med Chem. 36:1993;1923-1937.
2. Kukielka G.L., Youker K.A., Kawkins H.K. Regulation of ICAM-1 and IL-6 in myocardial ischemia effect of reperfusion . Ann NY Acad Sci. 723:1994;258-270.
3. Kay M.A., Liu D., Hoogerbrugge P.M. Gene therapy. Proc Natl Acad Sci USA. 94:1997;12744-12746.
4. Feeley B.T., Vriens P.W., Hoyt G., Ennen M.P., Robbins R.C. Increased pressure for ex vivo transfection of antisense oligodeoxynucleotides in cardiac allografts improves transfection efficiency. [Abstract] Transplantation. 65:1998;256.
5. Pollman M.J., Hall J.L., Mann M.J., Zhang L., Gibbons G.H. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat Med. 4:1998;222-227.
6. Poston R., Ennen M.P., Pollard J., Hoyt E.G., Billingham M.E., Robbins R.C. Ex vivo gene therapy prevents chronic graft vascular disease in cardiac allografts. J Thorac Cardiovasc Surg. 116:1998;386-396.
7. Stein C.A., Cheng Y.C. Antisense oligonucleotides as therapeutic agents is the bullet really magical? Science. 261:1993;1004-1012.
8. Akhtar S., Kole R., Juliano R.L. Stability of antisense DNA oligonucleotides in cellular extracts and sera. Life Sci. 49:1991;1793-1801.
9. Eder P.S., DeVine R.J., Walder J.A. Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3' exonuclease in plasma. Antisense Res Dev. 1:1991;141-151.
10. Gumina R.J., Newman P.J., Kenny D., Warltier D.C., Gross G.J. The leukocyte cell adhesion cascade and its role in myocardial ischemia-reperfusion injury. Basic Res Cardiol. 92:1997;201-213.
11. Butcher E.C. Leukocyte-endothelial cell recognition three (or more) steps of specificity and diversity . Cell. 67:1991;1033-1036.
12. Williams F.M. Neutrophils and myocardial reperfusion injury. Pharmacol Ther. 72:1996;1-12.
13. Springer T.A. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol. 57:1995;827-872.
14. Tohma S., Hirohata S., Lipsky P.E. The role of CD11a/CD54-CD54 interaction in human T cell-dependent B cell activation. J Immunol. 146:1991;492-499.
15. Diamond M.S., Staunton D.E., deFougerolles A.R., et al. ICAM-1 (CD54) a counter-receptor of Mac-1 (CD11b/CD18) . J Cell Biol. 11:1990;3129-3139.
16. Tamiya Y., Yamamoto N., Uede T. Protective effect of monoclonal antibodies against LFA-1 and ICAM-1 on myocardial reperfusion injury following global ischemia in rat hearts. Immunopharmacology. 57:1996;53-63.
17. Soriano S.G., Lipton S.A., Wang Y.F., et al. Intercellular adhesion molecule-1-deficient mice are less susceptible to cerebral ischemia-reperfusion injury. Ann Neurol. 39:1996;618-624.
18. Kelly K.J., Williams W.W. Jr, Colvin R.B., et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest. 97:1996;1056-1063.
19. Chiang M.Y., Chen H., Zounes M.A., Freier S.M., Lima W.F., Bennett F.C. Antisense oligonucleotides inhibit intercellular adhesion molecule-1 expression by two distinct mechanisms. J Biol Chem. 266:1991;18162-18171.
20. Stepkowski S.M., Tu Y., Condon T.P., Bennett C.F. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. J Immunol. 153:1994;5336-5346.
21. Ono K., Lindsey E.S. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg. 57:1969;225-229.
22. Barone F.C., Hillegass L.M., Price W.J., et al. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue myeloperoxidase activity assay and histologic verification . J Neurosci Res. 29:1991;226-345.
23. Isobe M., Suzuki J.I., Yamazaki S., Horie S., Okubo Y., Sekiguchi M. Assessment of tolerance induction to cardiac allograft by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies. J Heart Lung Transplant. 16:1997;1149-1156.